Next Article in Journal
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease
Next Article in Special Issue
Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study
Previous Article in Journal
Evaluation of a Clinical Index as a Predictive Tool for Primary Ciliary Dyskinesia
Previous Article in Special Issue
Sarcoidosis: An Old but Always Challenging Disease
Review

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes

1
New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA 70112, USA
2
Comprehensive Pulmonary Hypertension Center and Interstitial Lung Disease Clinic Programs, University Medical Center, New Orleans, LA 70112, USA
3
Section of Pulmonary Medicine, Louisiana State University School of Medicine, New Orleans, LA 70112, USA
4
Tulane University School of Medicine, Tulane University, New Orleans, LA 70112, USA
5
College of Medicine and Health, University of Exeter, Devon EX1 2LU, UK
6
Imperial College Healthcare NHS Foundation Trust, London W2 1NY, UK
7
Department of Internal Medicine, Oregon Health and Science University, Portland, OR 97239, USA
8
Respiratory Medicine, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter EX2 5DW, UK
9
Department of Neurology, National Jewish Health, Denver, CO 80206, USA
10
Sarcoidosis UK, China Works, Black Prince Road, London SE1 7SJ, UK
11
Foundation for Sarcoidosis Research, Chicago, IL 60614, USA
12
National Sarcoidosis Support Group, Stronger than Sarcoidosis, New York, NY 11727, USA
13
CGI UK, Space Defense & Intelligence (Cyber Security Operations), London EC3M 3BY, UK
14
Sarcoidosis Awareness Foundation of Louisiana, Baton Rouge, LA 70812, USA
15
New Orleans Sarcoidosis Support Group, New Orleans, LA 70112, USA
16
iHart Wellness Holistic Approach to Sarcoidosis Certified Health & Wellness Coach, International Association of Professionals, New York, NY 11727, USA
17
Department of Physiotherapy, Gelderse Vallei Hospital, 10, 6716 RP Ede, The Netherlands
18
ildcare Foundation Research Team, 6711 NR Ede, The Netherlands
19
Admiraal de Ruyter Hospital (Adrz), 114, 4462 RA Goes, The Netherlands
20
Department of Medical and Clinical Psychology, Tilburg University, 5037 AB Tilburg, The Netherlands
21
Cutaneous Sarcoidosis Clinic, Department of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA
22
Division of Pulmonary Medicine, Interstitial Lung Disease Center, University of Utah, Salt Lake City, UT 84132, USA
23
Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
24
Division of Rheumatology, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
25
Division of Pulmonary Medicine and Critical Care, Albany Medical College, Albany, NY 12208, USA
26
Interstitial Lung Diseases (ILD) Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands
27
Department of Pharmacology and Toxicology, Faculty of Health and Life Sciences, Maastricht University, 40, 6229 ER Maastricht, The Netherlands
*
Authors to whom correspondence should be addressed.
Academic Editor: Claudio Tana
Diagnostics 2021, 11(6), 1089; https://doi.org/10.3390/diagnostics11061089
Received: 30 April 2021 / Revised: 30 May 2021 / Accepted: 2 June 2021 / Published: 15 June 2021
(This article belongs to the Special Issue Diagnosis and Management of Sarcoidosis)
Health-related quality of life (HRQoL), though rarely considered as a primary endpoint in clinical trials, may be the single outcome reflective of patient priorities when living with a health condition. HRQoL is a multi-dimensional concept that reflects the degree to which a health condition interferes with participation in and fulfillment of important life areas. HRQoL is intended to capture the composite degree of physical, physiologic, psychological, and social impairment resulting from symptom burden, patient-perceived disease severity, and treatment side effects. Diminished HRQoL expectedly correlates to worsening disability and death; but interventions addressing HRQoL are linked to increased survival. Sarcoidosis, being a multi-organ system disease, is associated with a diffuse array of manifestations resulting in multiple symptoms, complications, and medication-related side effects that are linked to reduced HRQoL. Diminished HRQoL in sarcoidosis is related to decreased physical function, pain, significant loss of income, absence from work, and strain on personal relationships. Symptom distress can result clearly from a sarcoidosis manifestation (e.g., ocular pain, breathlessness, cough) but may also be non-specific, such as pain or fatigue. More complex, a single non-specific symptom, e.g., fatigue may be directly sarcoidosis-derived (e.g., inflammatory state, neurologic, hormonal, cardiopulmonary), medication-related (e.g., anemia, sleeplessness, weight gain, sub-clinical infection), or an indirect complication (e.g., sleep apnea, physical deconditioning, depression). Identifying and distinguishing underlying causes of impaired HRQoL provides opportunity for treatment strategies that can greatly impact a patient’s function, well-being, and disease outcomes. Herein, we present a reference manual that describes the current state of knowledge in sarcoidosis-related HRQoL and distinguish between diverse causes of symptom distress and other influences on sarcoidosis-related HRQoL. We provide tools to assess, investigate, and diagnose compromised HRQoL and its influencers. Strategies to address modifiable HRQoL factors through palliation of symptoms and methods to improve the sarcoidosis health profile are outlined; as well as a proposed research agenda in sarcoidosis-related HRQoL. View Full-Text
Keywords: sarcoidosis; quality of life; symptom burden; symptom distress; shared decision making; patient-centeredness; patient centered care; mindfulness; exercise; physical activity sarcoidosis; quality of life; symptom burden; symptom distress; shared decision making; patient-centeredness; patient centered care; mindfulness; exercise; physical activity
Show Figures

Figure 1

MDPI and ACS Style

Saketkoo, L.A.; Russell, A.-M.; Jensen, K.; Mandizha, J.; Tavee, J.; Newton, J.; Rivera, F.; Howie, M.; Reese, R.; Goodman, M.; Hart, P.; Strookappe, B.; De Vries, J.; Rosenbach, M.; Scholand, M.B.; Lammi, M.R.; Elfferich, M.; Lower, E.; Baughman, R.P.; Sweiss, N.; Judson, M.A.; Drent, M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics 2021, 11, 1089. https://doi.org/10.3390/diagnostics11061089

AMA Style

Saketkoo LA, Russell A-M, Jensen K, Mandizha J, Tavee J, Newton J, Rivera F, Howie M, Reese R, Goodman M, Hart P, Strookappe B, De Vries J, Rosenbach M, Scholand MB, Lammi MR, Elfferich M, Lower E, Baughman RP, Sweiss N, Judson MA, Drent M. Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics. 2021; 11(6):1089. https://doi.org/10.3390/diagnostics11061089

Chicago/Turabian Style

Saketkoo, Lesley A., Anne-Marie Russell, Kelly Jensen, Jessica Mandizha, Jinny Tavee, Jacqui Newton, Frank Rivera, Mike Howie, Rodney Reese, Melanie Goodman, Patricia Hart, Bert Strookappe, Jolanda De Vries, Misha Rosenbach, Mary B. Scholand, Mathew R. Lammi, Marjon Elfferich, Elyse Lower, Robert P. Baughman, Nadera Sweiss, Marc A. Judson, and Marjolein Drent. 2021. "Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes" Diagnostics 11, no. 6: 1089. https://doi.org/10.3390/diagnostics11061089

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop